Moreover, pathways associated with CDK12 loss showed considerable concordance between HGSC samples and prostate cancer with presumptive CDK12 inactivation (Fig. 1D, see SI Appendix, Fig. S1B). Here, CDK12 is linked to Familial prostate cancer.